Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Northbrook, IL NAICS: 541714
U.S. Department of Labor's OFLC discloses 34 Labor Condition Application filings naming Astellas Pharma Global Development, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 63 H-1B petitions naming Astellas Pharma Global Development, Inc. through FY2024, and approved nearly every one of them: 98.4% approved (62 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Astellas Pharma Global Development, Inc. is listed in 34 DOL LCA filings, more filings than 94% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $161,850. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Northbrook, IL.
Astellas Pharma Global Development, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
34 7370th of 122824 higher than 115,454 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $87,000–$428,500 .
DOL LCA release change
On 34 LCAs with comparable offered vs prevailing wages, Astellas Pharma Global Development, Inc. averages about 33.1% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (50% of LCA filings).
Certification Rate
100%
Very high DOL cert
Avg. Salary
$161,850
Well above portal avg
Total Workers
34
Small worker count
Compensation range for H-1B positions at Astellas Pharma Global Development, Inc.
Wage vs. DOL Minimum
+33.1%
High vs DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
50% of LCA filings
Full-Time Positions
100%
Primary Worksite County
COOK, IL
50% of LCA filings
Most frequently listed job titles at Astellas Pharma Global Development, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Statistical Scientist | 2 | $139,953 |
| Senior Manager, Clinical Data Digital Health Lead | 2 | $122,470 |
| Senior Manager, CPED Oncology [20357.321.8] | 2 | $131,914 |
| Senior Manager, CPED Oncology | 2 | $161,459 |
| Senior Centralized Monitoring Manager | 2 | $167,475 |
| Manager, Biostatistics | 2 | $130,988 |
| Information and Systems Strategy Manager | 2 | $130,000 |
| Chief Medical Officer | 2 | $409,551 |
| Statistical Programming Lead | 1 | $131,300 |
| Sr. Manager Real World Data & Evidence - Analytics | 1 | $125,300 |
| Sr. Associate Regulatory Affairs | 1 | $87,000 |
| Specialist, Regulatory Affairs (RA) CMC | 1 | $151,308 |
| Senior Regulatory Operations Manager | 1 | $146,286 |
| Senior Manager, Biostatistics - Oncology | 1 | $125,300 |
| Senior Manager Scientific Content Excellence | 1 | $130,187 |
Cross-state DOL neighbors for Astellas Pharma Global Development, Inc. - LCA filing-count and offered-wage axes, outside IL.
Nearest cross-state employer filers by LCA filing count (34 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($161,850 here).
Astellas Pharma Global Development, Inc. is listed in 34 DOL Labor Condition Application filings covering 34 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Astellas Pharma Global Development, Inc. ranks #7194 by total LCA filing count (34 filings). 115,454 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Astellas Pharma Global Development, Inc. has a 100% DOL certification rate, with 34 out of 34 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Astellas Pharma Global Development, Inc.'s LCAs is $161,850. Listed wages range from $87,000 to $428,500 and are not verified actual compensation.
The top job titles in Astellas Pharma Global Development, Inc.'s LCA filing records include Statistical Scientist, Senior Manager, Clinical Data Digital Health Lead, Senior Manager, CPED Oncology [20357.321.8]. The most common listed title is Statistical Scientist with 2 LCA filings at an average listed offered wage of $139,953. This does not establish actual job openings, hiring, or approved petitions.
Astellas Pharma Global Development, Inc. is headquartered in Northbrook, IL. Their H-1B workers are distributed across 7 states, with the most positions in IL, CA, MA.
No, Astellas Pharma Global Development, Inc. is not classified as H-1B dependent.
Astellas Pharma Global Development, Inc. is listed in 14 LCA filings in FY2023 and 1 in FY2026. The average listed offered wage increased from $136,091 to $140,275. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 34 LCAs (Δ 0 heavier vs Astellas Pharma Global Development, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 34 LCAs (Δ 0 heavier vs Astellas Pharma Global Development, Inc.); CERT-LOCK · WAGE-ELITE vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 34 LCAs (Δ 0 heavier vs Astellas Pharma Global Development, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 34 LCAs (Δ 0 heavier vs Astellas Pharma Global Development, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
IL pole at 11,656 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Astellas Pharma Global Development, Inc.'s MICRO-BOOK.
Open the IL state board after the ABS peers. Astellas Pharma Global Development, Inc. stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Astellas Pharma Global Development, Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Astellas Pharma Global Development, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.